哈密看妇科有名医院(哈密哪个专业治男科) (今日更新中)

BEIJING, Oct. 11 (Xinhuanet) -- An experimental drug that can remove amyloid plaques from the brains of Alzheimer's patients is being developed by Swiss Roche Holding AG in a small early-stage study, according to a report published in the Archives of Neurology on Monday.Researchers suspect the build-up of such plaques may be a cause of the memory robbing disease, although that theory has yet to be definitively proved. Gantenerumab, a biotech drug designed to bind to amyloid plaques in the brain and remove them, is being targeted at the early stages of Alzheimer's with the hope it can slow progression of the disease while patients are still able to function.The Phase I study of 16 Alzheimer's patients tested gantenerumab at two doses against a placebo over six months of treatment.The Roche drug led to a dose-dependent reduction of brain amyloid, while amyloid load increased in patients receiving a placebo, the report said.The next step will be to investigate whether removal of brain amyloid translates into clinical benefit for patients at doses of the experimental drug that are well tolerated and safe, the report said.Much larger trials and further study will be needed to fully understand how gantenerumab works and whether it can stave off Alzheimer's, said the report.Roche is approaching the disease far earlier because amyloid accumulates for 15 years before dementi.

SAN FRANCISCO, Nov. 14 (Xinhua) -- Google is running a secret research lab in the San Francisco Bay Area, where the tech giant invests to experiment and invent what may be world-changing technologies for the future, U.S. media reported on Monday.According to The New York Times, at the lab dubbed Google X, engineers are working at some 100 projects from robots, smart refrigerators to Internet-enabled dinner plates and a "space elevator," a proposed non-rocket space launch structure.An unnamed Google engineer familiar with the lab told the newspaper that it was run as mysteriously as the CIA with two officers, a nondescript one for logistics on the company's Mountain View campus and one for robots in a secret location.Scientists working at the lab include many roboticists and electrical engineers hired from Microsoft, Nokia labs, Stanford, MIT, Carnegie Mellon and New York University. Google's co-founder Sergey Brin is said to be "deeply involved" in Google X.The lab is reportedly headed by Sebastian Thrun, one of the world's top robotics and artificial intelligence experts. He teaches computer science at Stanford University and invented the world's first self-driving car.A Google spokeswoman would not confirm the existence of the lab, but said Google likes to invest in speculative projects."While the possibilities are incredibly exciting, please do keep in mind that the sums involved are very small by comparison to the investments we make in our core businesses," she told The New York Times.

BEIJING, Oct. 12 (Xinhuanet) -- Study found that women who took multivitamins may actually be at risk, media reports on Wednsday.Women who took the dietary supplements vitamin B6, folic acid, magnesium, zinc, copper, iron and multivitamins had a higher risk of death than women who did not.The new study, published in the Archives of Internal Medicine, examined more than 38,000 women aged 55 and older who took part in the Iowa Women's Health Study, which started in the mid 1980s. Researchers found the vitamins did nothing to reduce the risk of death and that most supplements have no positive effect on women's health.The study did not distinguish if the women in the study took the vitamins to fight diseases or to maintain health.Vitamin experts say the best way to make sure you are getting all necessary vitamins is to eat a well-balanced diet. The vitamins people take do not  depend on personal preference.

TEHRAN, Oct. 9 (Xinhua) -- Iran is going to launch domestically- built Navid satellite by Safir satellite launcher by the end of March 2012, the semi-official Mehr news agency reported on Sunday.Navid (promise) is a research satellite and is currently undergoing pre-launch tests, said the report without further details.In June, Iran put the Rasad (surveillance) satellite in the orbit to render images to the country.Iran put a satellite into orbit in 2009 and sent some small animals into space in 2010. It plans to send man into space by 2020.

BEIJING, Nov. 28 (Xinhuanet) -- A majority of the emergency hospitalizations for bad events related to medication use in old U.S. adults stem from four common medications, according to a new study in the New England Journal of Medicine Monday.The study was conducted by researchers from the Centers for Disease Control and Prevention of U.S.There are nearly 100,000 emergency hospitalizations for adverse drug events in older Americans, says researcher Daniel S. Budnitz, MD, MPH, director of the CDC's Medication Safety Program.And the four types of medication -- two for diabetes and two blood-thinning agents -- account for two-thirds of those drug-related emergency hospitalizations. They most often cited: warfarin (Coumadin, Jantoven); insulin; antiplatelet drugs such as aspirin and clopidogrel (Plavix); oral hypoglycemic agents."Both blood thinners and diabetes medicines are critical drugs that can be lifesaving," Budnitz says.However, he says that ''these are medications that you do need to pay attention to," being sure the dose and timing are correct, among other measures.

来源：资阳报